Investigation of the Roles of Viral Proteinases in the Vaccinia Virus Life Cycle Jessica Page Mentor: Dr. Dennis Hruby Department of Microbiology.

Slides:



Advertisements
Similar presentations
Biotechnology Chapter 11.
Advertisements

Vaccinia Virus G1L Protein Expression and Purification HHMI Summer Undergraduate Research Program 2004 Laboratory of Dr. Dennis Hruby Oregon State University.
Viral Detection By: Douglas Tran.  Past research  States Prion hypothesis and past research of no past viral genetic material detected  States the.
PRESENTED BY: LAUREN SHIN MENTOR: DR. LUIZ BERMUDEZ MICROBIOLOGY DEPARTMENT Determining the Role of the luxR homolog in Mycobacterium avium subsp. paratuberculosis.
Fig 1: HIV-1/HCV and HIV-1/HBV Co-Infection/Co- Culture Systems Philippe A. Gallay 1, Udayan Chatterji 1, Michael Bobardt 1, Daren Ure 2, Dan Trepanier.
The Disulfide Bonding Pattern of Vaccinia Virus Protein L1R Cliff Gagnier Dr. Dennis Hruby’s Lab September 1, 2004.
Pox Proteomics: Identification of the Proteins Associated with the Membranous Fraction of Vaccinia Virus Cliff Gagnier Dr. Dennis Hruby Department of Microbiology.
From Principles of Virology, Academic Press 2004 Cryo EM of purified Poxvirus particles 30 nm-thick surface domain (S)b is noted Poxviruses.
Production of Turnip yellow mosaic virus Capsids: The Future in Micronutrient Delivery Nicole Dzialowy Dr. Yannis Tzanetakis Dr. Theo Dreher Department.
1 Inhibitors of Other Viruses A. RIBAVIRIN Ribavirin (Virazole) is a nucleoside analogue in which a triazolecarboxamide moiety is substituted on place.
This is better then a cartoon! Chris Clark Infected with SV40!?!? Nope he’s just passed out again!
Biochemical Defects Associated with Cancer-Causing Pathogenic Mutations in Human MLH1 Andrew Nguyen Laboratory of Dr. Andrew Buermeyer Department of Environmental.
Viral structure, classification and replication Deborah E. Sullivan, Ph.D. Department of Microbiology and Immunology
Center for Biological Sequence Analysis The Technical University of Denmark DTU Comparative Microbial Genomics group Towards a “Systems Microbiology” of.
Viruses Chapter Nature of Viruses All viruses have same basic structure -Nucleic acid core surrounded by capsid Nucleic acid can be DNA or RNA;
Prevention and Diagnosis of Viral Diseases Deborah E. Sullivan, Ph.D. Department of Microbiology and Immunology
Bacteria and Viruses. Bacteria are prokaryotes Pro – before Karyon – nucleus The simplest forms of life Earth’s first cells.
Tetherin inhibits HIV-1 release by directly tethering virions to cells
Involvement of PP6 in Dephosphorylation of Bcl11b (an Anti-Tumorigenic Transcription Factor) University Honors College Thesis by Chelsea Parker Dept. Biochemistry.
What do you know about Viruses? 1. What are the 5 most common viral infections? 2. Name 2 similarities between a virus and a bacteria? 3. Name 2 differences.
27 MAR 2007 Antiviral Drugs: An Overview Chris Brooks CHEM 5398 Medicinal Chemistry Prof. Buynak.
Branches of Microbiology Bacteriology Virology Mycology Parasitology Immunology Recombinant DNA technology.
General Characteristics of Viruses
Mouse Models of Prostate Cancer Name: Vicki Javier Mentor: Todd Hricik Institution: MSKCC.
Susceptibility to Ranavirus Through Frogs and Salamanders Using q-PCR For Detection and Quantification Thomas Brigman Department of Biology, York College.
Viral Anatomy Envelope Forms from host membrane Forms from host membrane Viral genome includes genes for surface proteins Viral genome includes genes.
Scientific Reading and Writing in English discussion Shu-ying Wang, Ph.D. Dept. Microbiology and Immunology Tel: ext Fax:
Chapter 18.2 Viruses and Prions “Viruses and prions are smaller and less complex than bacteria; they invade cells and can alter cellular functions.”
Poxviruses. Introduction largest and most complex viruses Infections: characterized by a rash there is concern that the virus could be reintroduced as.
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease 1.
Pathogens: Good Parasites Gone Bad At the purely intellectual level there is little to differentiate a parasite that we tolerate or a symbiotic bacterium.
Susan L. Uprichard, PhD Director of Hepatology Research Loyola University Medical Center Department of Medicine Section of Hepatology HepNet 2013 HCV Virology.
The Antiviral Response in Plants: RNA Silencing Melissa Andreas Carrington Lab HHMI - Oregon State University Summer 2007.
Translational efficiency of Dengue Virus(DEN) and DEN variants in cells. Andrew Regan - Microbiology DREHER LAB - ALS1065.
This is the image of a bacterium being attacked by viral particles. You can see the contrast in size easily. In ancient Rome, ‘virus’ meant “poison” or.
Tobacco Mosaic Virus. Disclaimer This workforce solution was funded by a grant awarded under the President’s Community-Based Job Training Grants as implemented.
Chapter 18 - Viruses. Structure A virus is a non-living particle A virus is a non-living particle Composed of DNA or RNA and a protein coat Composed of.
Tet-Off® and Tet-On® Gene Expression Systems
Recombinant Hormones and Drugs.  Many human disorders traced to absence or malfunction of a protein normally synthesized in the body  eg. Sickle cell.
APPLICATIONS OF ANIMAL CELL CULTURE
Virology – replication and genetics JU- 2nd Year Medical Students
Live visualization of hemagglutinin dynamics during infection by using biarsenically labeled replication competent Influenza A virus Shashank Tripathi1,2,
Ch. 19 Warm-up Question to answer-
Biology Notebook 1st Period By: Camilo Andrés Garzón 8B.
Yujiao Yang, Chao Shan, Jing Zou, Antonio E
The distribution and function of the Adenovirus L4-33K protein
Transitions in Public Health
Viral Genetics.
Poxviruses Poxviridae
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure  C. Suñé, L. Brennan, D.R. Stover,
Wild‐type p53 binds and represses Rad51 promoter.
Viruses.
Volume 134, Issue 7, Pages (June 2008)
Volume 135, Issue 5, Pages e2 (November 2008)
Replication life cycle of HIV and sites of antiretroviral drug action.
VIRUSES.
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure  C. Suñé, L. Brennan, D.R. Stover,
Volume 23, Issue 10, Pages (October 2015)
Volume 7, Issue 1, Pages (January 2003)
RAD51 is essential for L. donovani.
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
Volume 85, Issue 7, Pages (June 1996)
Cytoplasmic ATR Activation Promotes Vaccinia Virus Genome Replication
Volume 22, Issue 12, Pages (March 2018)
Poxviral B1 Kinase Overcomes Barrier to Autointegration Factor, a Host Defense against Virus Replication  Matthew S. Wiebe, Paula Traktman  Cell Host.
Chapter 18.2 Viruses and Prions
An Inhibitory Activity in Human Cells Restricts the Function of an Avian-like Influenza Virus Polymerase  Andrew Mehle, Jennifer A. Doudna  Cell Host.
Volume 24, Issue 4, Pages (July 2018)
Volume 23, Issue 10, Pages (June 2018)
Presentation transcript:

Investigation of the Roles of Viral Proteinases in the Vaccinia Virus Life Cycle Jessica Page Mentor: Dr. Dennis Hruby Department of Microbiology

Vaccinia Virus: A close relative to variola virus, the causative agent of smallpox. Vaccinia Background

The Disease Smallpox (variola major) Highly infectious 30-40% mortality Effective vaccine (VV) Global eradication in 1977 Remaining variola stocks to be destroyed in 2002 Biological threat gone ……or is it?

Significance Smallpox has become a possible weapon of bioterrorism Smallpox has become a possible weapon of bioterrorism U.S. population has become immunologically naïve U.S. population has become immunologically naïve Vaccine not totally effective in attack situation Vaccine not totally effective in attack situation

Selection of appropriate antiviral target Proteinase inhibitor paradigm (HIV, HCV, etc.) Poxvirus proteinases Scientific Approach I7L G1L

Morphogenic Proteolysis VV Replication Cycle

P4b (72 kDa) Amino Acids AGS AGA 252 P25K (28 kDa) 1832 P4a (97 kDa) 617 AGS 697 AGT AGA 60 VV Core Protein Cleavage Sites K (25 kDa) 4b (62 kDa) 4a (64 kDa)23K Virion core formation

I7LG1LTetO TRex293 Cell TetRepressor I7LG1LTetO TRex293 Cell TetRepressor Tetracycline Operator/Repressor I7LG1L Viral DNA vvTetO:G1L/I7L TetO No expression of G1L & I7L Tetracycline Expression of G1L & I7L TetR Tet “OFF” “ON”

ABC DEF Viral Phenotype +/- Tetracycline + tet - tet

My Goals Characterize the vvTetO:G1L/I7L modified virus Characterize the vvTetO:G1L/I7L modified virus Growth curve +/- tet vs. WR to demonstrate conditional lethality and fitness Growth curve +/- tet vs. WR to demonstrate conditional lethality and fitness Western blots of I7L and late core proteins p4a, p4b, p25K +/- tet vs. WR and transfected with G1L/I7L plasmids Western blots of I7L and late core proteins p4a, p4b, p25K +/- tet vs. WR and transfected with G1L/I7L plasmids Rescue with I7L and G1L alone and in tandem to demonstrate activity of each proteinase independently Rescue with I7L and G1L alone and in tandem to demonstrate activity of each proteinase independently Analysis of core protein processing Analysis of core protein processing

Genomic Sequencing Tetracycline Operator = TCCCTATCAGTGATAGAGA I7LTGATAATCCCTATCAGTGATAGAGAATGGAAAGATA G1LAAATGATCCCTATCAGTGATAGAGAATGATTGTCTT TetO Methionine Promoter (upstream)

MOI Optimization + tet - tet

Growth Curve

Immunoblot Detection of p4b Protein Cleavage p4b precursor 72 kDa 4b cleavage product 62 kDa + tet-tetWR

P4b (72 kDa) Amino Acids AGS AGA 252 P25K (28 kDa) 1832 P4a (97 kDa) 617 AGS 697 AGT AGA 60 VV Core Protein Cleavage Sites K (25 kDa) 4b (62 kDa) 4a (64 kDa)23K Virion core formation

Immunoblot Detection of p4b Protein Cleavage p4b precursor 72 kDa 4b cleavage product 62 kDa + tet-tetWR

I7LG1LTetO TRex293 Cell TetRepressor Rescue Experiments TetR G1L plasmid I7L plasmid Expression of G1L and/or I7L Virion core formation and continuation of virus life cycle

Future Progress Continue to optimize experimental conditions to achieve successful rescue and analysis of late core proteins Continue to optimize experimental conditions to achieve successful rescue and analysis of late core proteins Try rescue with mutant I7L and G1L plasmids to determine the functional areas of the proteins Try rescue with mutant I7L and G1L plasmids to determine the functional areas of the proteins

THANKS!! Dr. Dennis Hruby Dr. Dennis Hruby Megan, Jen, Cliff, Chelsea, Kady, Su-Jung, Dina, Eric, and all the family Megan, Jen, Cliff, Chelsea, Kady, Su-Jung, Dina, Eric, and all the family Howard Hughes Medical Institute Howard Hughes Medical Institute